Puravankara Limited Strong Financial Turnaround Reported for FY 2026

Puravankara Limited has announced a robust financial performance for the fiscal year ended March 31, 2026. The company reported a significant turnaround in its financial health, with consolidated revenue from operations reaching ₹3,739.83 crore. Net profit for the year stood at ₹56.75 crore, marking a notable improvement compared to the losses recorded in the previous year. The company also strengthened its leadership team with the appointment of a new Chief Risk Officer.

Annual Financial Performance

For the financial year ended March 31, 2026, Puravankara Limited achieved a consolidated revenue of ₹3,739.83 crore. This reflects significant growth compared to the ₹2,013.61 crore reported in the previous fiscal year. The company successfully transitioned from a consolidated net loss of ₹182.92 crore in FY 2025 to a net profit of ₹56.75 crore in FY 2026, demonstrating an effective operational recovery.

Quarterly Highlights

In the final quarter (Q4: Jan-Mar 2026), the company recorded consolidated revenue of ₹1,069.31 crore, compared to ₹541.57 crore in the same period last year. The consolidated net profit for Q4 2026 was reported at ₹109.95 crore, a strong performance against the loss of ₹88.00 crore reported in Q4 2025.

Strategic Developments

During the fiscal year, the company expanded its growth initiatives, including the issuance of debentures by several wholly-owned subsidiaries to raise ₹1,017 crore through private placement. Furthermore, the company has strengthened its senior management team by appointing Mr. Amit Narain Ahuja as the Chief Risk Officer, effective May 4, 2026. Mr. Ahuja brings over 26 years of leadership experience to the organization.

Operational Updates

The company continues to maintain a single reportable segment focused on real estate development. Management has noted ongoing legal proceedings regarding land acquisitions and tax matters but maintains that these will not significantly impact the company’s financial position, as no additional provisions have been required at this time based on current legal evaluations.

Source: BSE

Previous Article

JK Paper Ltd Strong Q4 and Annual Performance with 40% Dividend Announcement

Next Article

Max Healthcare Completes Acquisition of Kalinga Hospital Ltd.